Ruda Vera M, Chandwani Rohit, Sehgal Alfica, Bogorad Roman L, Akinc Akin, Charisse Klaus, Tarakhovsky Alexander, Novobrantseva Tatiana I, Koteliansky Victor
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Laboratory of Immune Cell Epigenetics and Signaling, Rockefeller University, New York, New York, United States of America.
PLoS One. 2014 Jul 3;9(7):e101749. doi: 10.1371/journal.pone.0101749. eCollection 2014.
Argonaute 2 (Ago2) is the only mammalian Ago protein capable of mRNA cleavage. It has been reported that the activity of the short interfering RNA targeting coding sequence (CDS), but not 3' untranslated region (3'UTR) of an mRNA, is solely dependent on Ago2 in vitro. These studies utilized extremely high doses of siRNAs and overexpressed Ago proteins, as well as were directed at various highly expressed reporter transgenes. Here we report the effect of Ago2 in vivo on targeted knockdown of several endogenous genes by siRNAs, targeting both CDS and 3'UTR. We show that siRNAs targeting CDS lose their activity in the absence of Ago2, whereas both Ago1 and Ago3 proteins contribute to residual 3'UTR-targeted siRNA-mediated knockdown observed in the absence of Ago2 in mouse liver. Our results provide mechanistic insight into two components mediating RNAi under physiological conditions: mRNA cleavage dependent and independent. In addition our results contribute a novel consideration for designing most efficacious siRNA molecules with the preference given to 3'UTR targeting as to harness the activity of several Ago proteins.
Argonaute 2(Ago2)是唯一能够切割mRNA的哺乳动物AGO蛋白。据报道,靶向mRNA编码序列(CDS)而非3'非翻译区(3'UTR)的短干扰RNA的活性,在体外仅依赖于Ago2。这些研究使用了极高剂量的小干扰RNA(siRNA)并过表达AGO蛋白,并且针对各种高表达的报告转基因。在这里,我们报告了Ago2在体内对通过靶向CDS和3'UTR的siRNA对几种内源基因进行靶向敲低的影响。我们表明,靶向CDS的siRNA在没有Ago2的情况下失去活性,而Ago1和Ago3蛋白都有助于在小鼠肝脏中没有Ago2的情况下观察到的残留的3'UTR靶向的siRNA介导的敲低。我们的结果为生理条件下介导RNA干扰的两个成分提供了机制上的见解:mRNA切割依赖性和非依赖性。此外,我们的结果为设计最有效的siRNA分子提供了新的考虑因素,优先考虑3'UTR靶向以利用几种AGO蛋白的活性。